Hong Kong SAR

Bank of Tianjin has commenced pre-deal investor education to test the waters for its $1bn Hong Kong IPO, say bankers.

Hong Kong MTR Corp’s tightly priced HK$15bn ($1.9bn) loan has attracted interest from more than 20 banks in syndication, according to sources.

Malaysia Building Society (MBSB) has announced a two-call rights issue that will see it raise up to MR2bn ($487m) from shareholders.

China’s city bank IPOs are in the limelight again as a pair of regional lenders prepare to launch Hong Kong listings worth billions of dollars. But with China stepping up capital curbs to keep outflows in check and foreign investors still wary of Chinese equities, these deals will be in an even tighter spot than usual. John Loh reports.

Hutchison China MediTech’s (Chi-Med) $100m IPO on the Nasdaq was oversubscribed three days into bookbuilding, even as bankers pinned their hopes on a select group of US funds.

These may be difficult days for bankers, given how up and down deal flow has been since the beginning of the year. However, privately many seem happy enough to be indulging in some unexpected free time.

Bank of China plans to list its aircraft lessor in Hong Kong in a deal that could raise $2bn by mid-year. The move swiftly follows China Development Bank, which has also filed an IPO of its leasing arm.

Bank of America Merrill Lynch has lost a member of its equity capital markets syndicate team in Hong Kong and a DCM banker in South Korea, sources said this week.

Bank of America Merrill Lynch has lost a member of its equity capital markets syndicate team in Hong Kong, according to sources.

China Zheshang Bank is gauging demand for a $1.5bn-$1.6bn IPO in Hong Kong and plans to launch the trade next week.

Hutchison China MediTech’s (Chi-Med) $100m IPO on the Nasdaq has been oversubscribed three days into bookbuilding, according to sources close to the transaction.

Union Medical Healthcare has priced its HK$742.4m ($95.5m) Hong Kong IPO close to the floor of the expected range, as investor sensitivity meant the issuer chose prudence over price.